期刊文献+

2012~2013加拿大高血压教育计划解读和启示 被引量:3

下载PDF
导出
摘要 加拿大是全球高血压疾病防控最好的国家之一,这与加拿大高血压教育计划(Canadian Hypertension Education Program,CHEP)每年对最新发表的临床试验结果深入解析并制订新一年诊疗推荐计划密不可分。CHEP优点:①更新快,将最新循证证据迅速转化指导临床实践;②更新内容显示清晰,方便阅读,易于掌握。2012~2013 CHEP根据高血压领域最新循证证据,对高血压诊断、评估和治疗推荐进行更新,其管理运行模式对我国高血压防控工作具有重要借鉴意义。
作者 石静 李悦
出处 《中国医学前沿杂志(电子版)》 2013年第9期61-64,共4页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 辉瑞中国高血压科研基金(WS1932120)
  • 相关文献

参考文献22

  • 1Kearney PM,Whelton M,Reynolds K. Global burden of hypertension:analysis of worldwide data[J].{H}LANCET,2005,(9455):217-223.
  • 2McAlister FA,Wilkins K,Joffres M. Changes in the rates of awareness,treatment and control of hypertension in Canada over the past two decades[J].{H}CMAJ:Canadian Medical Association Journal,2011,(09):1007-1013.
  • 3Campbell NR,Brant R,Johansen H. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada[J].{H}HYPERTENSION,2009,(02):128-134.
  • 4Daskalopoulou SS,Khan NA,Quinn RR. The 2012 Canadian hypertension education program recommendations for the management of hypertension:blood pressure measurement,diagnosis,assessment of risk,and therapy[J].{H}Canadian Journal of Cardiology,2012,(03):270-287.
  • 5Ohkubo T,Kikuya M,Metoki H. Prognosis of"masked"hypertension and "white coat" hypertension detected by 24-h ambulatory blood pressure monitoring[J].{H}Journal of the America College of Cardiology,2005,(02):508-515.
  • 6Warren RE,Marshall T,Padfield PL. Variability of ofifce,24-hour ambulatory,and self-monitored blood pressure measurements[J].{H}British Journal of General Practice,2010,(578):675-680.
  • 7Bobrie G,Chatellier G,Genes N. Cardiovascular prognosis of"masked hypertension"detected by blood pressure self-measurement in elderly treated hypertensive patients[J].{H}JAMA:the Journal of the American Medical Association,2004,(11):1342-1349.
  • 8Rabi DM,Daskalopoulou SS,Padwal RS. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension:blood pressure measurement,diagnosis,assessment of risk,and therapy[J].{H}Canadian Journal of Cardiology,2011,(04):415-433.e1-e2.
  • 9Pitt B,Zannad F,Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.Randomized Aldactone Evaluation Study Investigators[J].{H}New England Journal of Medicine,1999,(10):709-717.
  • 10Pitt B,Bakris G,Ruilope LM. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)[J].{H}CIRCULATION,2008,(16):1643-1650.

二级参考文献22

共引文献1215

同被引文献29

引证文献3

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部